로딩 중…
지수 로딩 중…
Veradermics, Incorporated
MANE· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$101.86-2.99%
2026-08-03
Financials
Valuation Metrics
Veradermics, Incorporated's Market Cap is $4.26B. Ranked #1515 of 3,112 in US market (top 49%), #990 of 1,667 on NYSE (top 59%), #86 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 32%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.26B | US#1,515/3,112 Sec#86/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-70M | US—/3,112 Sec—/269 |
| Total Assets | $153M | US#3,003/3,112 Sec#254/269 |
| Net Assets | $-121M | US#3,014/3,112 Sec#266/269 |
| Value | ||
| FCF Yield | -1.68% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROA | -45.86% | US#2,953/3,112 Sec#208/269 |
| Financial Health | ||
| Total Debt | $4000.00 | US#2,976/3,112 Sec#264/269 |
| FCF | $-72M | US#2,524/3,112 Sec#127/269 |
| Cash | $22M | US#2,842/3,112 Sec#259/269 |
| Current Ratio | 16.66x | US#149/3,112 Sec#46/269 |
| Performance | ||
| 1M Return | -21.49% | US#2,971/3,112 Sec#238/269 |
| From 52W High | -22.38% | US#1,829/3,112 Sec#120/269 |
| 1Y MDD | -21.49% | US#804/3,112 Sec#38/269 |
| Trading | ||
| Volume | 2,664,522 shares | US#693/3,112 Sec#60/269 |
| Trading Value | $266M | US#408/3,112 Sec#18/269 |